FUSOGENIX
PIPELINE
ABOUT
NEWS
CONTACT
News & Publications
April 24, 2023
Entos Presenting at Bloom Burton & Co. Healthcare Investor Conference April 25
Published by:
Perrin H Beatty
February 27, 2023
Talking Biotech Podcast with Kevin Folta. Reinventing Lipid Nanoparticles - John Lewis
Published by:
Perrin H Beatty
January 5, 2023
Event: Entos in San Francisco for JPM Week 2023
Published by:
November 8, 2022
ASTech 2022 Award for Outstanding Achievement in Health: Entos Pharmaceuticals!
Published by:
Perrin Beatty
November 2, 2022
Event on Now: Boulder Peptide Symposium 2022
Published by:
Perrin Beatty
November 2, 2022
Event on now: 5th Annual Evercore ISI HealthCONx Conference
Published by:
Perrin Beatty
September 28, 2022
Press Release: Entos Passes Significant Enrollment Milestone in Phase 2 Clinical Trial of its COVID-19 DNA Vaccine
Published by:
Perrin Beatty
August 25, 2022
Edmonton Global Video: Transforming Our Economy with Entos Pharmaceuticals
Published by:
Perrin Beatty
July 19, 2022
Entos at the Next Generation Lipid-Based Nanoparticles Delivery Summit
Published by:
Perrin Beatty
June 7, 2022
Press Release: Entos Expands R&D Operations into the US
Published by:
Perrin Beatty
March 18, 2020
Press Release: Entos Pharmaceuticals Developing DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform
Published by:
Entos Pharmaceuticals
December 20, 2019
HICKS ON BIZ: The University of Alberta’s next big thing
Published by:
Graham Hicks
November 1, 2018
Entos Pharmaceuticals joins JLABS San Diego
Published by:
Entos Pharmaceuticals
July 2, 2018
Entos awarded entry into the Merck Invention Accelerator
Published by:
Entos Pharmaceuticals
March 30, 2018
Entos and Oisin Bio Announce Fusogenix License for SENSOlytics™
Published by:
Entos Pharmaceuticals
June 26, 2018
Entos and Oisin Bio Launch OncoSenX: A Spinoff Company Targeting Cancer
Published by:
John D. Lewis, PhD
November 13, 2018
Precision Nanosystems and Entos sign license agreement
Published by:
PRESS RELEASE (Precision NanoSystems)
Entos Pharmaceuticals
33 St James's Square
London, UK, SW1Y 4JS
Unit 4550, 10230 Jasper Avenue
Edmonton, Alberta, Canada
T5J 4P6
3040 Science Park Road,Suite 1100
San Diego, CA 92121
General Contact
Tel: 1-800-727-0884
Email:
info@entospharma.com
Investor Contact
Email:
info@entospharma.com
Media Contact
Email:
media@entospharma.com
Name
Email Address
Company Name
Message
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.